Aperam (APEMY)
(Delayed Data from OTC)
$29.24 USD
+0.74 (2.60%)
Updated Apr 24, 2024 09:47 AM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
APEMY 29.24 +0.74(2.60%)
Will APEMY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for APEMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APEMY
Is Aperam (APEMY) Stock Undervalued Right Now?
All You Need to Know About Aperam (APEMY) Rating Upgrade to Strong Buy
APEMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Aperam (APEMY) Stock?
Aperam (APEMY) Flat As Market Sinks: What You Should Know
Are Basic Materials Stocks Lagging Aperam (APEMY) This Year?
Other News for APEMY
Aperam price target lowered by EUR 1 at Barclays
Aperam price target lowered by EUR 3 at Morgan Stanley
Aperam price target lowered by EUR 0.90 at JPMorgan
Aperam price target lowered by EUR 0.90 at JPMorgan
Aperam price target lowered by EUR 1 at Deutsche Bank